Preclinical Study: Sunitinib-suppressed MiR-452-5p Facilitates Renal Cancer Cell Invasion and Metastasis Through Modulating SMAD4/SMAD7/EMT Signals

Saiyang Li(Shanghai Tenth People's Hospital), Yunfei Xu(Shanghai Tenth People's Hospital)
bioRxiv (Cold Spring Harbor Laboratory)
March 22, 2018
Cited by 1


Related Papers